Mitral Regurgitation Chronic: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
There are two surgical options for the treatment of mitral regurgitation: mitral valve replacement and mitral valve repair. | There are two surgical options for the treatment of mitral regurgitation: mitral valve replacement and mitral valve repair. | ||
===[[MR Surgical | ===[[MR Surgical Indications|Indication for Surgery]]=== | ||
===[[MR ACC/AHA guidelines for management|ACC/AHA guidelines for management]]=== | ===[[MR ACC/AHA guidelines for management|ACC/AHA guidelines for management]]=== | ||
Revision as of 00:45, 25 February 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch. Individuals with chronic mitral regurgitation can be treated with vasodilators as well. In the chronic state, the most commonly used agents are ACE inhibitors and hydralazine. Studies have shown that the use of ACE inhibitors and hydralazine can delay surgical treatment of mitral regurgitation1,2. The current guidelines for treatment of mitral regurgitation limit the use of vasodilators to individuals with hypertension
There are two surgical options for the treatment of mitral regurgitation: mitral valve replacement and mitral valve repair.